Tina Paradzik

Dr. Tina Paradzik

Rudjer Boskovic Institute, Zagreb, Zagreb, Grad, Croatia
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2015 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
RDRobert Duran
Robert Duran
ABAna Bielen
Ana Bielen
TPTina Paradzik
Tina Paradzik
CGClaire Gassie
Claire Gassie
EPEmina Pustijanac
Emina Pustijanac
DVDušica Vujaklija
Dušica Vujaklija

11 March 2021 in Cancers
Verified
Journal Article
Open access
PDF file
TPTina Paradzik
Tina Paradzik
CBCecilia Bandini
Cecilia Bandini
EMElisabetta Mereu
Elisabetta Mereu
MLMaría Labrador
María Labrador
ETElisa Taiana
Elisa Taiana
Roberto PivaRoberto Piva
Roberto Piva
Multiple myeloma is a malignancy of terminally differentiated plasma cells, characterized by an extreme genetic heterogeneity that poses great challenges for its successful treatment. Due to antibody overproduction, MM cells depend on the precise regulation of the protein degradation systems. Despite the success of PIs in MM treatment, resistance and adverse toxic effects such as peripheral neuropathy and cardiotoxicity could arise. To this end, the use of rational combinatorial treatments might allow lowering the dose of inhibitors and therefore, minimize their side-effects. Even though the suppression of different cellular pathways in combination with proteasome inhibitors have shown remarkable anti-myeloma activities in preclinical models, many of these promising combinations often failed in clinical trials. Substantial progress has been made by the simultaneous targeting of proteasome and different aspects of MM-associated immune dysfunctions. Moreover, targeting deranged metabolic hubs could represent a new avenue to identify effective therapeutic combinations with PIs. Finally, epigenetic drugs targeting either DNA methylation, histone modifiers/readers, or chromatin remodelers are showing pleiotropic anti-myeloma effects alone and in combination with PIs. We envisage that the positive outcome of patients will probably depend on the availability of more effective drug combinations and treatment of early MM stages. Therefore, the identification of sensitive targets and aberrant signaling pathways is instrumental for the development of new personalized therapies for MM patients.

15 February 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
LPLucija Perković
Lucija Perković
EDElvis Djedović
Elvis Djedović
TVTamara Vujović
Tamara Vujović
MBMarija Baković
Marija Baković
TPTina Paradzik
Tina Paradzik
RČRozelindra Čož-Rakovac
Rozelindra Čož-Rakovac
The diversity of algal species is a rich source of many different bioactive metabolites. The compounds extracted from algal biomass have various beneficial effects on health. Recently, co-culture systems between microalgae and bacteria have emerged as an interesting solution that can reduce the high contamination risk associated with axenic cultures and, consequently, increase biomass yield and synthesis of active compounds. Probiotic microorganisms also have numerous positive effects on various aspects of health and represent potent co-culture partners. Most studies consider algae as prebiotics that serve as enhancers of probiotics performance. However, the extreme diversity of algal organisms and their ability to produce a plethora of metabolites are leading to new experimental designs in which these organisms are cultivated together to derive maximum benefit from their synergistic interactions. The future success of these studies depends on the precise experimental design of these complex systems. In the last decade, the development of high-throughput approaches has enabled a deeper understanding of global changes in response to interspecies interactions. Several studies have shown that the addition of algae, along with probiotics, can influence the microbiota, and improve gut health and overall yield in fish, shrimp, and mussels aquaculture. In the future, such findings can be further explored and implemented for use as dietary supplements for humans.

1 April 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
AMAna Martić
Ana Martić
LČLara Čižmek
Lara Čižmek
NUNikolay Ul’yanovskii
Nikolay Ul’yanovskii
TPTina Paradzik
Tina Paradzik
LPLucija Perković
Lucija Perković
RČRozelindra Čož-Rakovac
Rozelindra Čož-Rakovac
The marine environment has a significant impact on life on Earth. Organisms residing in it are vital for the ecosystem but also serve as an inexhaustible source of biologically active compounds. Herein, the biodiversity of two brown seaweeds, Dictyota dichotoma and Dictyota fasciola from the Adriatic Sea, was evaluated. The aim of the study was the determination of differences in compound composition while comparing their activities, including antioxidant, antimicrobial, and enzyme inhibition, in connection to human digestion, dermatology, and neurological disorders. Chemical analysis revealed several terpenoids and steroids as dominant molecules, while fucoxanthin was the main identified pigment in both algae. D. dichotoma had higher protein, carbohydrate, and pigment content. Omega-6 and omega-3 fatty acids were identified, with the highest amount of dihomo-γ-linolenic acid and α-linolenic acid in D. dichotoma. Antimicrobial testing revealed a dose-dependent inhibitory activity of methanolic fraction against Escherichia coli and Staphylococcus aureus. Moderate antioxidant activity was observed for both algae fractions, while the dietary potential was high, especially for the D. fasciola dichloromethane fraction, with inhibition percentages of around 92% for α-amylase and 57% for pancreatic lipase at 0.25 mg/mL. These results suggest that Dictyota species might be a potent source of naturally derived agents for obesity and diabetes.

1 January 2021 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
VBVladimir Bermanec
Vladimir Bermanec
TPTina Paradzik
Tina Paradzik
SKSnježana Kazazić
Snježana Kazazić
CVChantelle Venter
Chantelle Venter
JHJasna Hrenović
Jasna Hrenović
BBBlazo Boev
Blazo Boev

6 February 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
TPTina Paradzik
Tina Paradzik
NINives Ivic
Nives Ivic
ZFZelimira Filic
Zelimira Filic
BMBabu A. Manjasetty
Babu A. Manjasetty
PHPaul Herron
Paul Herron
DVDusica Vujaklija
Dusica Vujaklija
The linear chromosome of Streptomyces coelicolor contains two paralogous ssb genes, ssbA and ssbB. Following mutational analysis, we concluded that ssbA is essential, whereas ssbB plays a key role in chromosome segregation during sporulation. In the ssbB mutant, ∼30% of spores lacked DNA. The two ssb genes were expressed differently; in minimal medium, gene expression was prolonged for both genes and significantly upregulated for ssbB. The ssbA gene is transcribed as part of a polycistronic mRNA from two initiation sites, 163 bp and 75 bp upstream of the rpsF translational start codon. The ssbB gene is transcribed as a monocistronic mRNA, from an unusual promoter region, 73 bp upstream of the AUG codon. Distinctive DNA-binding affinities of single-stranded DNA-binding proteins monitored by tryptophan fluorescent quenching and electrophoretic mobility shift were observed. The crystal structure of SsbB at 1.7 Å resolution revealed a common OB-fold, lack of the clamp-like structure conserved in SsbA and previously unpublished S-S bridges between the A/B and C/D subunits. This is the first report of the determination of paralogous single-stranded DNA-binding protein structures from the same organism. Phylogenetic analysis revealed frequent duplication of ssb genes in Actinobacteria, whereas their strong retention suggests that they are involved in important cellular functions.